Healthcare provider profile · identity verified

Amra Suljevic

Nurse Practitioner · TWIN FALLS, ID · NPI 1811354640

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	396	108
Levothyroxine Sodium	Levothyroxine Sodium	276	74
Omeprazole	Omeprazole	271	77
Gabapentin	Gabapentin	206	67
Pantoprazole Sodium	Pantoprazole Sodium	188	60
Furosemide	Furosemide	185	51
Lisinopril	Lisinopril	185	51
Losartan Potassium	Losartan Potassium	173	51
Trazodone Hcl	Trazodone Hcl	166	56
Potassium Chloride	Potassium Chloride	141	44
Amlodipine Besylate	Amlodipine Besylate	137	49
Metformin Hcl Er	Metformin Hcl	132	39
Montelukast Sodium	Montelukast Sodium	109	29
Duloxetine Hcl	Duloxetine Hcl	108	30
Citalopram Hbr	Citalopram Hydrobromide	100	27
Metoprolol Succinate	Metoprolol Succinate	100	29
Ozempic	Semaglutide	97	18
Eliquis	Apixaban	96	24
Hydrochlorothiazide	Hydrochlorothiazide	95	26
Fluticasone Propionate	Fluticasone Propionate	94	44
Albuterol Sulfate Hfa	Albuterol Sulfate	87	43
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	87	29
Famotidine	Famotidine	85	30
Hydroxyzine Hcl	Hydroxyzine Hcl	81	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	80	20
Sertraline Hcl	Sertraline Hcl	77	20
Glipizide Er	Glipizide	74	22
Tizanidine Hcl	Tizanidine Hcl	72	21
Pregabalin	Pregabalin	67	15
Alendronate Sodium	Alendronate Sodium	66	20
Quetiapine Fumarate	Quetiapine Fumarate	60	11
Tramadol Hcl	Tramadol Hcl	60	23
Bupropion Xl	Bupropion Hcl	55	23
Simvastatin	Simvastatin	50	17
Lorazepam	Lorazepam	49	14
Metformin Hcl	Metformin Hcl	49	14
Spironolactone	Spironolactone	49	14
Celecoxib	Celecoxib	48	17
Fluoxetine Hcl	Fluoxetine Hcl	48	12
Rosuvastatin Calcium	Rosuvastatin Calcium	48	17
Donepezil Hcl	Donepezil Hcl	45	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	45	suppressed
Trulicity	Dulaglutide	44	11
Aripiprazole	Aripiprazole	43	suppressed
Jardiance	Empagliflozin	43	suppressed
Allopurinol	Allopurinol	39	14
Propranolol Hcl	Propranolol Hcl	39	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	38	suppressed
Meloxicam	Meloxicam	38	17
Tamsulosin Hcl	Tamsulosin Hcl	35	11
Amitriptyline Hcl	Amitriptyline Hcl	31	suppressed
Alprazolam	Alprazolam	30	11
Pravastatin Sodium	Pravastatin Sodium	30	suppressed
Clopidogrel	Clopidogrel Bisulfate	29	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	29	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	29	suppressed
Prednisone	Prednisone	29	26
Zolpidem Tartrate	Zolpidem Tartrate	29	suppressed
Buspirone Hcl	Buspirone Hcl	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Amiodarone Hcl	Amiodarone Hcl	27	suppressed
Finasteride	Finasteride	27	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Carvedilol	Carvedilol	26	suppressed
Clonazepam	Clonazepam	26	suppressed
Sucralfate	Sucralfate	26	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	26	12
Dicyclomine Hcl	Dicyclomine Hcl	25	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Ondansetron Odt	Ondansetron	24	11
Nystatin	Nystatin	23	12
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	12
Warfarin Sodium	Warfarin Sodium	21	suppressed
Estradiol	Estradiol	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Atenolol	Atenolol	19	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	17
Arnuity Ellipta	Fluticasone Furoate	17	suppressed
Azithromycin	Azithromycin	17	17
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Dilt-Xr	Diltiazem Hcl	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Baclofen	Baclofen	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Prazosin Hcl	Prazosin Hcl	11	suppressed
Topiramate	Topiramate	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error